In Brief: Diametrics Medical, Inc.
This article was originally published in The Gray Sheet
Diametrics Medical, Inc.: Introduces next-generation IRMA SL (immediate response mobile analysis) point-of-care blood testing system July 29 at the American Association of Clinical Chemistry annual meeting in Chicago. The firm is on track with its strategy announced in January to launch the product in mid-1996 ("The Gray Sheet" Jan. 15, I&W-1). The new system will be priced at $8,500, $2,500 higher than the company's first-generation system. About 500 original IRMA devices have been placed in about 300 hospitals in the U.S. to date, the firm says...
You may also be interested in...
Celltrion has announced plans to add a third biopharmaceutical facility and a new global biotechnology research center at the Korean firm’s existing site in Songdo, Incheon, as the firm also revealed record third-quarter financial results.
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.